Gould Capital’s Medpace MEDP Stock Holding History

Gould Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.4K	Hold	150	–	–	0.04%	76
2026 Q1	$72K	Hold	150	–	–	0.04%	72
2025 Q4	$84.2K	Hold	150	–	–	0.05%	69
2025 Q3	$77.1K	Hold	150	–	–	0.05%	71
2025 Q2	$47.1K	Hold	150	–	–	0.03%	84
2025 Q1	$45.7K	Hold	150	–	–	0.03%	82
2024 Q4	$49.8K	Hold	150	–	–	0.03%	81
2024 Q3	$50.1K	Hold	150	–	–	0.03%	83
2024 Q2	$61.8K	Hold	150	–	–	0.04%	78
2024 Q1	$60.6K	Hold	150	–	–	0.04%	78
2023 Q4	$46K	Hold	150	–	–	0.03%	91
2023 Q3	$36.4K	Hold	150	–	–	0.03%	89
2023 Q2	$36K	Hold	150	–	–	0.03%	94
2023 Q1	$28.2K	Hold	150	–	–	0.02%	102
2022 Q4	$31.9K	Hold	150	–	–	0.03%	98
2022 Q3	$24K	Hold	150	–	–	0.02%	101
2022 Q2	$22K	Hold	150	–	–	0.02%	101
2022 Q1	$25K	Sell	150 -6,455	-98%	-$1.06M	0.02%	103
2021 Q4	$1.44M	Buy	+6,605	New	+$1.38M	1.01%	28

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gould Capital's MEDP Position: Q2 2026 in Review

Gould Capital held its Medpace (MEDP) position steady in Q2 2026 at 150 shares worth $79.4K. The position accounts for 0.04% of the portfolio, ranked #76.

Gould Capital first reported a position in MEDP in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.44M in Q4 2021. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Gould Capital held 150 shares of Medpace worth $79.4K as of Q2 2026.
Gould Capital left its Medpace share count unchanged in Q2 2026.
Medpace made up 0.04% of Gould Capital's portfolio in Q2 2026, its #76 holding.
Gould Capital first reported a position in Medpace in Q4 2021 and has held it in 19 quarters since.
Gould Capital's Medpace position peaked at $1.44M in Q4 2021.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.